Loading patent…
AssigneesUniversity-Industry Cooperation Group of Kyung Hee University, Elphis Cell Therapeutics
InventorsHyun Sook HONG, Dae Yeon HWANG, Suna KIM, Youngsook SON
Estimating the term…
The present invention relates to a composition comprising vascular endothelial progenitor cells and mesenchymal stem cells as active ingredients for prevention or treatment of occlusive vascular diseases or complications thereof. Since it was found that vascular endothelial progenitor cells and mesenchymal stem cells remarkably improved vascularization ability upon application thereof in combination, the present invention has the effect of providing a new cell therapy product for prevention or treatment of occlusive vascular diseases or ulcers resulting therefrom, and a preparation method therefore.
A method for treating an occlusive vascular disease or an ulcer resulting therefrom, the method comprising administering a composition comprising vascular endothelial progenitor cells and mesenchymal stem cells as active ingredients to a subject in need thereof.
A preparation method of a composition for prevention or treatment of an occlusive vascular disease or an ulcer resulting therefrom, comprising mixing vascular endothelial progenitor cells and mesenchymal stem cells.
(canceled)
(canceled)
Dependencies are inferred from the claim text.